secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cardiff Oncology, Inc. (CRDF)
CIK:        0001213037
Form:       8-K
Filed at:   2025-01-06T23:59:59+00:00
Accession:  0000950170-25-002076
Event type: other_material
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud

Cardiff Oncology amends and restates its bylaws effective January 3, 2025
-------------------------------------------------------------------------

- Board of Directors approved Amended and Restated Bylaws on January 3, 2025.
- The amended bylaws were filed as Exhibit 3.1 to the Form 8-K.
- No change in fiscal year was reported in connection with the amendment.
- The company is incorporated in Delaware and trades on Nasdaq under CRDF.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1213037/000095017025002076/0000950170-25-002076-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1213037/000095017025002076/crdf-20250103.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-002076

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer